Author Index Volume 5 (2015)
The issue number is given in front of the pagination
Aarsland, D. and M.G. Kramberger, Neuropsychiatric Symptoms in Parkinson’s Disease (3) 659-667
Aarsland, D., see Skogseth, R.E. (4) 783-792
Abbott, S.K., A.M. Jenner, A.S. Spiro, M. Batterham, G.M. Halliday and B. Garner, Fatty Acid Composition of the Anterior Cingulate Cortex Indicates a High Susceptibility to Lipid Peroxidation in Parkinson’s Disease (1) 175-185
Abreu, D., see Reimão, S. (3) 561-567
Achey, M.A., see Dorsey, E.R. (3) 505-515
Ács, P., see Deli, G. (2) 361-368
Adler, C.H., see Caviness, J.N. (1) 117-124
Adler, C.H., see Lin, T.P. (1) 125-130
Adler, J.S., see Lin, T.P. (1) 125-130
Agid, Y., The Concept of Subconsciousness in Alzheimer’s and Parkinson’s Diseases (3) 643-645
Ahmad, S.H., see Dorsey, E.R. (3) 505-515
Aita, S., see Cohen, M.L. (2) 351-359
Akbar, F., see Price, C.C. (4) 893-905
Al-Jawad, A., see Ferreira, J.J. (2) 281-290
Allen, N.E., N. Moloney, V. van Vliet and C.G. Canning, The Rationale for Exercise in the Management of Pain in Parkinson’s Disease (2) 229-239
Allen, N.E., see Almeida, L.R.S. (4) 855-864
Almeida, L.R.S., C. Sherrington, N.E. Allen, S.S. Paul, G.T. Valenca, J. Oliveira-Filho and C.G. Canning, Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson’s Disease Without a History of Falls: A One-Year Prospective Study (4) 855-864
Alvarado-Bolaños, A., A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Llorens-Arenas, H. Calderón-Fajardo, R. Millán-Cepeda, R. Leal-Ortega, I. Estrada-Bellmann and C. Zuñiga-Ramírez, Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson’s Disease (3) 541-548
Armstrong, R.A., Oculo-Visual Dysfunction in Parkinson’s Disease (4) 715-726
Aronsson, P., see Mitra, R. (2) 301-311
Aschermann, Z., see Deli, G. (2) 361-368
Ashkan, K., see Ughratdar, I. (3) 483-496
Aubertin-Leheudre, M., see Daneault, J.-F. (1) 85-93
Auburger, G., see Brehm, N. (3) 595-604
Auvinen, P., see Scheperjans, F. (2) 255-262
Avilés, E., see Stephenson, D. (3) 581-594
Baig, F., see Lawton, M. (2) 269-279
Bain, L.J., see Stephenson, D. (3) 581-594
Bajaj, N., see Malek, N. (4) 947-959
Baker, L., see Simon, D.K. (4) 731-736
Balás, I., see Deli, G. (2) 361-368
Balcer, L.J., see Lin, T.P. (1) 125-130
Balloy, G., see Preterre, C. (4) 765-772
Barbat-Artigas, S., see Daneault, J.-F. (1) 85-93
Barker, R.A., see Malek, N. (4) 947-959
Barker, R.A., see Yarnall, A.J. (4) 743-747
Barone, P., see Moccia, M. (4) 913-924
Bar-Shira, A., see Simon-Tov, S. (3) 525-531
Barton, B., see Westbay, L.C. (3) 497-504
Batterham, M., see Abbott, S.K. (1) 175-185
Bega, D., S. Kim, Y. Zhang, J. Elm, J. Schneider, R. Hauser, A. Fraser and T. Simuni on behalf of the NET-PD LS1 Investigators, Predictors of Functional Decline in Early Parkinson’s Disease: NET-PD LS1 Cohort (4) 773-782
Beijer, T.R., see Brodie, M.A.D. (1) 105-116
Béland, S.-G., R.B. Postuma, V. Latreille, J.-A. Bertrand, M. Panisset, S. Chouinard, C. Wolfson and J.-F. Gagnon, Observational Study of the Relation between Parkinson’s Disease and Sleep Apnea (4) 805-811
Belden, C.M., see Caviness, J.N. (1) 117-124
Benesh, J., see Slevin, J.T. (1) 165-174
Ben-Shlomo, Y., see Lawton, M. (2) 269-279
Ben-Shlomo, Y., see Malek, N. (4) 947-959
Ben-Shlomo, Y., see Stephenson, D. (3) 581-594
Bergquist, F., see Mitra, R. (2) 301-311
Bertrand, J.-A., see Béland, S.-G. (4) 805-811
Bettiol, S.S., T.C. Rose, C.J. Hughes and L.A. Smith, Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings (3) 425-442
Bhattaram, A., see Stephenson, D. (3) 581-594
Bichon, A., see Sierra, M. (3) 625-636
Biemiller, R.A., see Dorsey, E.R. (3) 505-515
Biglan, K.M., see Dorsey, E.R. (3) 505-515
Bliwise, D.L., see Scullin, M.K. (1) 49-54
Bloem, B.R., see Canoy, M. (3) 575-580
Bloem, B.R., see Domingos, J.M. (3) 453-469
Bloem, B.R., see Haaxma, C.A. (4) 847-853
Bloem, B.R., see Hassan, A. (2) 313-319
Bloem, B.R., see Nonnekes, J. (1) 43-47
Bloem, B.R., see van der Eijk, M. (4) 937-945
Bloem, B.R., see Zach, H. (3) 471-474
Bloem, B.R., see Zach, H. (4) 727-729
Bloem, B.R., see Zhao, Y. (2) 369-378
Bohnen, N.I., see Fasano, A. (2) 241-254
Bonizzoni, E., see Cattaneo, C. (3) 475-481
Borden, A., see Le Goff, F. (1) 95-104
Borenstein, A.R., see Sullivan, K.L. (4) 813-820
Borm, G.F., see Haaxma, C.A. (4) 847-853
Bosnyák, E., see Deli, G. (2) 361-368
Bowers, D., see Price, C.C. (4) 893-905
Boyd, J.T., see Parashos, S.A. (1) 67-73
Brandt, J., see Cohen, M.L. (2) 351-359
Breen, D.P., see Yarnall, A.J. (4) 743-747
Breen, K., see Stephenson, D. (3) 581-594
Brehm, N., K. Rau, A. Kurz, S. Gispert and G. Auburger, Age-Related Changes of 14-3-3 Isoforms in Midbrain of A53T-SNCA Overexpressing Mice (3) 595-604
Bresner, C., see Malek, N. (4) 947-959
Brodie, M.A.D., R.T. Dean, T.R. Beijer, C.G. Canning, S.T. Smith, J.C. Menant and S.R. Lord, Symmetry Matched Auditory Cues Improve Gait Steadiness in Most People with Parkinson’s Disease but not in Healthy Older People (1) 105-116
Bronnick, K., see Skogseth, R.E. (4) 783-792
Brooks, D., see Yarnall, A.J. (4) 743-747
Brooks, D.W., see Rocker, C. (1) 55-66
Brownlee, H.J., see Sullivan, K.L. (4) 813-820
Brundin, P., see George, S. (3) 413-424
Bull, M.T., see Dorsey, E.R. (3) 505-515
Burn, D., see Stephenson, D. (3) 581-594
Burn, D.J., see Malek, N. (4) 947-959
Burn, D.J., see Yarnall, A.J. (4) 743-747
Burnett-Zeigler, I., see Westbay, L.C. (3) 497-504
Burré, J., The Synaptic Function of α-Synuclein (4) 699-713
Butler, J.S., see Fearon, C. (4) 925-936
Cabrera-Zubizarreta, A., see Lucas-Jiménez, O. (4) 793-804
Calderón-Fajardo, H., see Alvarado-Bolaños, A. (3) 541-548
Campos, J., see Reimão, S. (3) 561-567
Canning, C.G., see Allen, N.E. (2) 229-239
Canning, C.G., see Almeida, L.R.S. (4) 855-864
Canning, C.G., see Brodie, M.A.D. (1) 105-116
Canoy, M., M.J. Faber, M. Munneke, W. Oortwijn, M.J. Nijkrake and B.R. Bloem, Hidden Treasures and Secret Pitfalls: Application of the Capability Approach to ParkinsonNet (3) 575-580
Cao, L., see Westbay, L.C. (3) 497-504
Capitanio, F., see Serrano, J.A. (1) 187-196
Cappelletti, L., see Dorsey, E.R. (3) 505-515
Cappelletti, L., see Rocker, C. (1) 55-66
Carlsson, T., see Mitra, R. (2) 301-311
Carnicella, S., see Sierra, M. (3) 625-636
Castrioto, A., see Sierra, M. (3) 625-636
Cattaneo, C., R. La Ferla, E. Bonizzoni and M. Sardina, Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis (3) 475-481
Cavanaugh, J.T., see Duncan, R.P. (1) 131-139
Caviness, J.N., J.G. Hentz, C.M. Belden, H.A. Shill, E.D. Driver-Dunckley, M.N. Sabbagh, J.J. Powell and C.H. Adler, Longitudinal EEG Changes Correlate with Cognitive Measure Deterioration in Parkinson’s Disease (1) 117-124
Cervantes-Arriaga, A., see Alvarado-Bolaños, A. (3) 541-548
Chabardes, S., see Sierra, M. (3) 625-636
Charles, D., see Tramontana, M.G. (1) 151-163
Chatamra, K., see Slevin, J.T. (1) 165-174
Chaudhuri, K.R., see Fauser, M. (4) 737-741
Cheong, Y.W., see Tan, A.H. (4) 865-879
Chesselet, M.-F., see Magen, I. (3) 669-680
Chou, K.L., see Parashos, S.A. (1) 67-73
Chouinard, S., see Béland, S.-G. (4) 805-811
Chowdhury, S., see Dorsey, E.R. (3) 505-515
Chowdhury, S., see Rocker, C. (1) 55-66
Chung, A., see Magen, I. (3) 669-680
Ciucci, M.R., see Kelm-Nelson, C.A. (4) 749-763
Clark-Matott, J., see Simon, D.K. (4) 731-736
Coelho MD, M., see Domingos, J.M. (3) 453-469
Coelho, M., see Reimão, S. (3) 561-567
Cohen, M.L., N.A. Schwab, C.C. Price and K.M. Heilman, Impaired Switching from Self-Prepared Actions in Mild Parkinson Disease (4) 961-970
Cohen, M.L., S. Aita, Z. Mari and J. Brandt, The Unique and Combined Effects of Apathy and Depression on Cognition in Parkinson’s Disease (2) 351-359
Comella, C.L., see Lamotte, G. (1) 21-41
Corbillé, A.-G., see Preterre, C. (4) 765-772
Corcos, D.M., see Lamotte, G. (1) 21-41
Cronin, R., see Lin, T.P. (1) 125-130
Cronin-Golomb, A., see Seichepine, D.R. (1) 75-83
Crosson, B., see Ellis, C. (2) 403-411
Cusumano, J.P., see Sterling, N.W. (1) 141-150
Dai, L., see Parashos, S.A. (1) 67-73
Damier, P., Why do Parkinson’s Disease Patients Sometimes Make Wrong Decisions? (3) 637-642
Daneault, J.-F., A.F. Sadikot, S. Barbat-Artigas, M. Aubertin-Leheudre, N. Jodoin, M. Panisset and C. Duval, Physical Activity in Advanced Parkinson’s Disease: Impact of Subthalamic Deep Brain Stimulation (1) 85-93
Däuper, J., see Münte, T.F. (3) 613-620
Davidsdottir, S., see Seichepine, D.R. (1) 75-83
Davis, T.L., see Tramontana, M.G. (1) 151-163
Dean, J., see Domingos, J.M. (3) 453-469
Dean, R.T., see Brodie, M.A.D. (1) 105-116
Defebvre, L., see Tard, C. (2) 379-387
Defebvre, L., see Tard, C. (3) 569-574
Deli, G., Z. Aschermann, P. Ács, E. Bosnyák, J. Janszky, B. Faludi, A. Makkos, M. Kovács, S. Komoly, I. Balás, T. Dóczi and N. Kovács, Bilateral Subthalamic Stimulation can Improve Sleep Quality in Parkinson’s Disease (2) 361-368
Delval, A., see Tard, C. (2) 379-387
Delval, A., see Tard, C. (3) 569-574
Demailly, F., see Tard, C. (3) 569-574
Dengler, R., see Münte, T.F. (3) 613-620
Derkinderen, P., see Preterre, C. (4) 765-772
Derrey, S., see Le Goff, F. (1) 95-104
Devick, S., see Lin, T.P. (1) 125-130
Devos, D., see Tard, C. (2) 379-387
DeWitte, S., see Mathur, S. (2) 263-268
Dibble, L.E., see Duncan, R.P. (1) 131-139
Dibble, L.E., see Hayes, H.A. (3) 549-560
Díez-Cirarda, M., see Lucas-Jiménez, O. (4) 793-804
Dinh, D., see Magen, I. (3) 669-680
Dinur, T., see Simon-Tov, S. (3) 525-531
Dirkx, M., see Zach, H. (3) 471-474
Dóczi, T., see Deli, G. (2) 361-368
Domingos, J., see Ferreira, J.J. (2) 281-290
Domingos, J., see Serrano, J.A. (1) 187-196
Domingos, J.M., C. Godinho, J. Dean, M. Coelho MD, A. Pinto, B.R. Bloem and J.J. Ferreira, Cognitive Impairment in Fall-Related Studies in Parkinson’s Disease (3) 453-469
Dorsey, E.R., J.D. Wagner, M.T. Bull, A. Rizzieri, J. Grischkan, M.A. Achey, T. Sherer, S. Chowdhury, C. Meunier, L. Cappelletti, C. Rocker, I.H. Richard, H. Schwarz, G. Kang, S.H. Ahmad, R.A. Biemiller and K.M. Biglan, Feasibility of Virtual Research Visits in Fox Trial Finder (3) 505-515
Dou, Y., see Jiao, Y. (2) 389-401
Dragunow, M., see Yang, P. (4) 821-836
Driver-Dunckley, E.D., see Caviness, J.N. (1) 117-124
Du, G., see Sterling, N.W. (1) 141-150
Dubow, J., see Slevin, J.T. (1) 165-174
Duffen, J., see Ferreira, J.J. (2) 281-290
Duffen, J., see Serrano, J.A. (1) 187-196
Duhamel, A., see Tard, C. (2) 379-387
Dujardin, K., see Tard, C. (2) 379-387
Dujardin, K., see Tard, C. (3) 569-574
Duncan, G.W., see Yarnall, A.J. (4) 743-747
Duncan, R.P., A.L. Leddy, J.T. Cavanaugh, L.E. Dibble, T.D. Ellis, M.P. Ford, K.B. Foreman and G.M. Earhart, Detecting and Predicting Balance Decline in Parkinson Disease: A Prospective Cohort Study (1) 131-139
Dunlop, S.R., see Simon, D.K. (4) 731-736
Duval, C., see Daneault, J.-F. (1) 85-93
Earhart, G.M., see Duncan, R.P. (1) 131-139
Eaton, S., see Slevin, J.T. (1) 165-174
Ebersbach, G., see Fauser, M. (4) 737-741
Egan, S.J., K. Laidlaw and S. Starkstein, Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease (3) 443-451
Ellis, C., B. Crosson, L.J.G. Rothi, M.S. Okun and J.C. Rosenbek, Narrative Discourse Cohesion in Early Stage Parkinson’s Disease (2) 403-411
Ellis, T.D., see Duncan, R.P. (1) 131-139
Elm, J., see Bega, D. (4) 773-782
Elm, J., see Parashos, S.A. (1) 67-73
Elm, J., see Simon, D.K. (4) 731-736
Elmer, L., see Nausieda, P.A. (4) 837-845
Elstein, D., see Simon-Tov, S. (3) 525-531
Emborg, M., see Simon, D.K. (4) 731-736
Erro, R., see Moccia, M. (4) 913-924
Estrada-Bellmann, I., see Alvarado-Bolaños, A. (3) 541-548
Faber, M.J., see Canoy, M. (3) 575-580
Faber, M.J., see van der Eijk, M. (4) 937-945
Factor, S.A., see Scullin, M.K. (1) 49-54
Fairley, J.A., see Scullin, M.K. (1) 49-54
Faludi, B., see Deli, G. (2) 361-368
Fasano, A., T. Herman, A. Tessitore, A.P. Strafella and N.I. Bohnen, Neuroimaging of Freezing of Gait (2) 241-254
Faull, R., see Yang, P. (4) 821-836
Fauser, M., M. Löhle, G. Ebersbach, P. Odin, G. Fuchs, W.H. Jost, K.R. Chaudhuri, R. Koch, NoMoFlu-PD study group and Alexander Storch, Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson’s Disease (4) 737-741
Fearon, C., J.S. Butler, L. Newman, T. Lynch and R.B. Reilly, Audiovisual Processing is Abnormal in Parkinson’s Disease and Correlates with Freezing of Gait and Disease Duration (4) 925-936
Fernandez, H.H., see Slevin, J.T. (1) 165-174
Ferreira, J., see Reimão, S. (3) 561-567
Ferreira, J.J., A.T. Santos, J. Domingos, H. Matthews, T. Isaacs, J. Duffen, A. Al-Jawad, F. Larsen, J.A. Serrano, P. Weber, A. Thoms, S. Sollinger, H. Graessner and W. Maetzler, Clinical Parameters and Tools for Home-Based Assessment of Parkinson’s Disease: Results from a Delphi study (2) 281-290
Ferreira, J.J., see Domingos, J.M. (3) 453-469
Ferreira, J.J., see Reimão, S. (3) 561-567
Ferreira, J.J., see Serrano, J.A. (1) 187-196
Fetter, D., see Le Goff, F. (1) 95-104
Filoteo, J.V., see Pirogovsky-Turk, E. (4) 971-981
Fladby, T., see Skogseth, R.E. (4) 783-792
Foltynie, T., see Malek, N. (4) 947-959
Ford, M.P., see Duncan, R.P. (1) 131-139
Ford, S., see Stephenson, D. (3) 581-594
Foreman, K.B., see Duncan, R.P. (1) 131-139
Fraser, A., see Bega, D. (4) 773-782
Friend, S., see Stephenson, D. (3) 581-594
Fuchs, G., see Fauser, M. (4) 737-741
Gagnon, J.-F., see Béland, S.-G. (4) 805-811
Galetta, S.L., see Lin, T.P. (1) 125-130
Gallacher, J., see Stephenson, D. (3) 581-594
Gardner, G.M., see Silbergleit, A.K. (3) 517-524
Garner, B., see Abbott, S.K. (1) 175-185
Garvan, C., see Price, C.C. (4) 893-905
Gasser, T., Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review (2) 209-215
George, S. and P. Brundin, Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation (3) 413-424
Gerrits, W.L.J., see Zach, H. (4) 727-729
Gil, R.A., see Nausieda, P.A. (4) 837-845
Giladi, N., see Hassan, A. (2) 313-319
Giladi, N., see Simon-Tov, S. (3) 525-531
Gilat, M., see Hall, J.M. (4) 881-891
Gill, C.E., see Tramontana, M.G. (1) 151-163
Gispert, S., see Brehm, N. (3) 595-604
Godinho, C., see Domingos, J.M. (3) 453-469
Goh, K.J., see Tan, A.H. (4) 865-879
Goldstein, F.C., see Scullin, M.K. (1) 49-54
Gonçalves, N., see Reimão, S. (3) 561-567
Gordon, M.F., see Stephenson, D. (3) 581-594
Goselink, R., see Nonnekes, J. (1) 43-47
Graebner, A.K., see Simon, D.K. (4) 731-736
Graessner, H., see Ferreira, J.J. (2) 281-290
Graessner, H., see Serrano, J.A. (1) 187-196
Grischkan, J., see Dorsey, E.R. (3) 505-515
Grosset, D., see Stephenson, D. (3) 581-594
Grosset, K.A., see Malek, N. (4) 947-959
Guan, J., see Yang, P. (4) 821-836
Guedes, L.C., see Reimão, S. (3) 561-567
Gupta, S., see Nausieda, P.A. (4) 837-845
Haak, M., see Nilsson, M.H. (4) 983-992
Haaxma, C.A., M.W.I.M. Horstink, J.C. Zijlmans, W.A.J.G. Lemmens, B.R. Bloem and G.F. Borm, Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson’s Disease (4) 847-853
Hall, C., see Slevin, J.T. (1) 165-174
Hall, J.M., J.M. Shine, C. O’Callaghan, C.C. Walton, M. Gilat, S.L. Naismith and S.J.G. Lewis, Freezing of Gait and its Associations in the Early and Advanced Clinical Motor Stages of Parkinson’s Disease: A Cross-Sectional Study (4) 881-891
Halliday, G.M., see Abbott, S.K. (1) 175-185
Hardy, J., see Malek, N. (4) 947-959
Harrington, D.L., see Pirogovsky-Turk, E. (4) 971-981
Hassan, A., S.S. Wu, P. Schmidt, T. Simuni, N. Giladi, J.M. Miyasaki, B.R. Bloem, I.A. Malaty, M.S. Okun and on behalf of the NPF QII Investigators, The Profile of Long-term Parkinson’s Disease Survivors with 20 Years of Disease Duration and Beyond (2) 313-319
Hauser, R., see Bega, D. (4) 773-782
Hayes, H.A., N. Hunsaker and L.E. Dibble, Implicit Motor Sequence Learning in Individuals with Parkinson Disease: A Meta-Analysis (3) 549-560
Hedera, P., see Tramontana, M.G. (1) 151-163
Heida, T., see Zhao, Y. (2) 369-378
Heilman, K.M., see Cohen, M.L. (4) 961-970
Heldmann, M., see Münte, T.F. (3) 613-620
Helmich, R.C., see Zach, H. (3) 471-474
Hentz, J.G., see Caviness, J.N. (1) 117-124
Hentz, J.G., see Lin, T.P. (1) 125-130
Herman, T., see Fasano, A. (2) 241-254
Ho, N.W.W., see Tan, A.H. (4) 865-879
Hoffmann, R., see Ma, J.K.-Y. (2) 291-299
Horstink, M.W.I.M., see Haaxma, C.A. (4) 847-853
Hsu, A., see Nausieda, P.A. (4) 837-845
Hu, M.T., see Stephenson, D. (3) 581-594
Hu, M.T.M., see Lawton, M. (2) 269-279
Huang, X. see Sterling, N.W. (1) 141-150
Hughes, C.J., see Bettiol, S.S. (3) 425-442
Hunsaker, N., see Hayes, H.A. (3) 549-560
Ibarretxe-Bilbao, N., see Lucas-Jiménez, O. (4) 793-804
Ippolito, D., see Westbay, L.C. (3) 497-504
Isaac, M., see Stephenson, D. (3) 581-594
Isaacs, T., see Ferreira, J.J. (2) 281-290
Isaacs, T., see Mathur, S. (2) 263-268
Isaacs,v, see Serrano, J.A. (1) 187-196
Iwarsson, S., see Jonasson, S.B. (2) 341-349
Iwarsson, S., see Nilsson, M.H. (4) 983-992
Jahanshahi, M., see Williams, I.A. (2) 321-331
Jan, M., see Le Goff, F. (1) 95-104
Janszky, J., see Deli, G. (2) 361-368
Jenner, A.M., see Abbott, S.K. (1) 175-185
Jiao, Y., Y. Dou, G. Lockwood, A. Pani and R.J. Smeyne, Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice (2) 389-401
Jodoin, N., see Daneault, J.-F. (1) 85-93
Jonasson, S.B., S. Ullén, S. Iwarsson, J. Lexell and M.H. Nilsson, Concerns About Falling in Parkinson’s Disease: Associations with Disabilities and Personal and Environmental Factors (2) 341-349
Joppich, G., see Münte, T.F. (3) 613-620
Jost, W.H., see Fauser, M. (4) 737-741
Ju, Y.-S., see Kim, Y.E. (3) 605-612
Kaakkola, S., see Scheperjans, F. (2) 255-262
Kamp, C., see Simon, D.K. (4) 731-736
Kang, G., see Dorsey, E.R. (3) 505-515
Kang, S.Y., see Kim, Y.E. (3) 605-612
Kell, S., see Nausieda, P.A. (4) 837-845
Kelm-Nelson, C.A., K.M. Yang and M.R. Ciucci, Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson’s Disease (4) 749-763
Khanna, S., see Nausieda, P.A. (4) 837-845
Khoo, T.K., see Yarnall, A.J. (4) 743-747
Kim, S., see Bega, D. (4) 773-782
Kim, Y.E., S.Y. Kang, H.-I. Ma, Y.-S. Ju and Y.J. Kim, A Visual Rating Scale for the Hummingbird Sign with Adjustable Diagnostic Validity (3) 605-612
Kim, Y.J., see Kim, Y.E. (3) 605-612
Klingelhoefer, L. and H. Reichmann, Parkinson’s Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options – A Practise Guide (3) 647-658
Koch, R., see Fauser, M. (4) 737-741
Koetsenruijter, J., see van der Eijk, M. (4) 937-945
Kohrt, W.M., see Lamotte, G. (1) 21-41
Komoly, S., see Deli, G. (2) 361-368
Kong, L., see Sterling, N.W. (1) 141-150
Kong, S.T., see Tan, A.H. (4) 865-879
Konrad, P.E., see Tramontana, M.G. (1) 151-163
Kovacs, G.G., see Pirker, S. (4) 907-912
Kovacs, G.G., see Rahimi, J. (2) 333-340
Kovács, M., see Deli, G. (2) 361-368
Kovács, N., see Deli, G. (2) 361-368
Krack, P., see Sierra, M. (3) 625-636
Kramberger, M.G., see Aarsland, D. (3) 659-667
Kubota, K., see Stephenson, D. (3) 581-594
Kurz, A., see Brehm, N. (3) 595-604
La Ferla, R., see Cattaneo, C. (3) 475-481
Laidlaw, K., see Egan, S.J. (3) 443-451
Lamotte, G., M.R. Rafferty, J. Prodoehl, W.M. Kohrt, C.L. Comella, T. Simuni and D.M. Corcos, Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson’s Disease: A Review (1) 21-41
Larsen, F., see Ferreira, J.J. (2) 281-290
Larsen, F., see Serrano, J.A. (1) 187-196
Latreille, V., see Béland, S.-G. (4) 805-811
Lawson, R.A., see Yarnall, A.J. (4) 743-747
Lawton, M., F. Baig, M. Rolinski, C. Ruffman, K. Nithi, M.T. May, Y. Ben-Shlomo and M.T.M. Hu, Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort (2) 269-279
Lawton, M.A., see Malek, N. (4) 947-959
Le Goff, F., S. Derrey, R. Lefaucheur, A. Borden, D. Fetter, M. Jan, D. Wallon and D. Maltête, Decline in Verbal Fluency After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: A Microlesion Effect of the Electrode Trajectory? (1) 95-104
Leal-Ortega, R., see Alvarado-Bolaños, A. (3) 541-548
Leddy, A.L., see Duncan, R.P. (1) 131-139
Lefaucheur, R., see Le Goff, F. (1) 95-104
Lehn, A.C., see Malek, N. (4) 947-959
Lemmens, W.A.J.G., see Haaxma, C.A. (4) 847-853
Letournel, F., see Preterre, C. (4) 765-772
Levy, S.-A., see Price, C.C. (4) 893-905
Lew, S.L.H., see Tan, A.H. (4) 865-879
Lewis, M.M., see Sterling, N.W. (1) 141-150
Lewis, S.J.G., see Hall, J.M. (4) 881-891
LeWitt, P.A., see Silbergleit, A.K. (3) 517-524
Lexell, J., see Jonasson, S.B. (2) 341-349
Lhommée, E., see Sierra, M. (3) 625-636
Lim, C.C., see Tan, A.H. (4) 865-879
Lim, Q.H., see Tan, A.H. (4) 865-879
Lim, S.-Y., see Tan, A.H. (4) 865-879
Limousin, P., see Williams, I.A. (2) 321-331
Lin, T.P., H. Rigby, J.S. Adler, J.G. Hentz, L.J. Balcer, S.L. Galetta, S. Devick, R. Cronin and C.H. Adler, Abnormal Visual Contrast Acuity in Parkinson’s Disease (1) 125-130
Little, M.A., see Stephenson, D. (3) 581-594
Litvan, I., see Pirogovsky-Turk, E. (4) 971-981
Liu, G., see Sterling, N.W. (1) 141-150
Llorens-Arenas, R., see Alvarado-Bolaños, A. (3) 541-548
Lobo, P.P., see Reimão, S. (3) 561-567
Lockwood, G., see Jiao, Y. (2) 389-401
Loh, K.W., see Tan, A.H. (4) 865-879
Löhle, M., see Fauser, M. (4) 737-741
Lord, S.R., see Brodie, M.A.D. (1) 105-116
Lovestone, S., see Stephenson, D. (3) 581-594
Lucas-Jiménez, O., M. Díez-Cirarda, N. Ojeda, J. Peña, A. Cabrera-Zubizarreta and N. Ibarretxe-Bilbao, Verbal Memory in Parkinson’s Disease: A Combined DTI and fMRI Study (4) 793-804
Lynch, T., see Fearon, C. (4) 925-936
Ma, H.-I., see Kim, Y.E. (3) 605-612
Ma, J.K.-Y., C.B. Schneider, R. Hoffmann and A. Storch, Speech Prosody Across Stimulus Types for Individuals with Parkinson’s Disease (2) 291-299
Maetzler, W., see Ferreira, J.J. (2) 281-290
Maetzler, W., see Serrano, J.A. (1) 187-196
Magen, I., E.R. Torres, D. Dinh, A. Chung, E. Masliah and M.-F. Chesselet, Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson’s Disease (3) 669-680
Mahamad, U.A., see Tan, A.H. (4) 865-879
Mahlknecht, P., K. Seppi and W. Poewe, The Concept of Prodromal Parkinson’s Disease (4) 681-697
Makkos, A., see Deli, G. (2) 361-368
Malaty, I.A., see Hassan, A. (2) 313-319
Malek, N., D.M.A. Swallow, K.A. Grosset, M.A. Lawton, S.L. Marrinan, A.C. Lehn, C. Bresner, N. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N.M. Williams, N. Wood and D.G. Grosset on behalf of the PRoBaND clinical consortium, Tracking Parkinson’s: Study Design and Baseline Patient Data (4) 947-959
Maltête, D., see Le Goff, F. (1) 95-104
Marek, K., see Stephenson, D. (3) 581-594
Mari, Z., see Cohen, M.L. (2) 351-359
Mari, Z., see Parashos, S.A. (1) 67-73
Marras, C., see Tan, A.H. (4) 865-879
Marrinan, S.L., see Malek, N. (4) 947-959
Marshall, C., see Rocker, C. (1) 55-66
Martin, A., see Matthews, H. (3) 533-539
Masliah, E., see Magen, I. (3) 669-680
Mathur, S., S. DeWitte, I. Robledo, T. Isaacs and J. Stamford, Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease (2) 263-268
Matthews, H., J. Stamford, R. Saha and A. Martin on behalf of the Off-Park survey steering group, Exploring Issues Around Wearing-off and Quality of Life: The OFF-PARK Survey of People with Parkinson’s Disease and their Care Partners (3) 533-539
Matthews, H., see Ferreira, J.J. (2) 281-290
Matthews, H., see Serrano, J.A. (1) 187-196
May, A.T., see Tramontana, M.G. (1) 151-163
May, M.T., see Lawton, M. (2) 269-279
Melki, R., Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases (2) 217-227
Menant, J.C., see Brodie, M.A.D. (1) 105-116
Meunier, C., see Dorsey, E.R. (3) 505-515
Meunier, C.C., see Rocker, C. (1) 55-66
Milenkovic, I., see Rahimi, J. (2) 333-340
Millán-Cepeda, R., see Alvarado-Bolaños, A. (3) 541-548
Mitra, R., P. Aronsson, M. Winder, G. Tobin, F. Bergquist and T. Carlsson, Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson’s Disease (2) 301-311
Miyasaki, J.M., see Hassan, A. (2) 313-319
Moccia, M., B. Mollenhauer, R. Erro, M. Picillo, R. Palladino and P. Barone, Non-Motor Correlates of Smoking Habits in de Novo Parkinson’s Disease (4) 913-924
Modi, N.B., see Nausieda, P.A. (4) 837-845
Molinari, A.L., see Tramontana, M.G. (1) 151-163
Mollenhauer, B., see Moccia, M. (4) 913-924
Mollenhauer, B., see Skogseth, R.E. (4) 783-792
Moloney, N., see Allen, N.E. (2) 229-239
Moreau, C., see Tard, C. (2) 379-387
Moreau, C., see Tard, C. (3) 569-574
Morgado, C., see Reimão, S. (3) 561-567
Morgan, J.C., see Parashos, S.A. (1) 67-73
Morgan, J.C., see Simon, D.K. (4) 731-736
Morris, H.R., see Malek, N. (4) 947-959
Morris, H.R., see Stephenson, D. (3) 581-594
Mortimer, J.A., see Sullivan, K.L. (4) 813-820
Munneke, M., see Canoy, M. (3) 575-580
Munneke, M., see van der Eijk, M. (4) 937-945
Münte, T.F., G. Joppich, J. Däuper, C. Schrader, R. Dengler and M. Heldmann, Random Number Generation and Executive Functions in Parkinson’s Disease: An Event-Related Brain Potential Study (3) 613-620
Naismith, S.L., see Hall, J.M. (4) 881-891
Nausieda, P.A., A. Hsu, L. Elmer, R.A. Gil, J. Spiegel, C. Singer, S. Khanna, R. Rubens, S. Kell, N.B. Modi and S. Gupta, Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials (4) 837-845
Neargarder, S., see Seichepine, D.R. (1) 75-83
Neimat, J.S., see Tramontana, M.G. (1) 151-163
Neunlist, M., see Preterre, C. (4) 765-772
Neutel, D., see Reimão, S. (3) 561-567
Newman, L., see Fearon, C. (4) 925-936
Nijhuis, F.A.P., see van der Eijk, M. (4) 937-945
Nijkrake, M.J., see Canoy, M. (3) 575-580
Nilsson, M.H., S. Iwarsson, B. Thordardottir and M. Haak, Barriers and Facilitators for Participation in People with Parkinson’s Disease (4) 983-992
Nilsson, M.H., see Jonasson, S.B. (2) 341-349
Nithi, K., see Lawton, M. (2) 269-279
Nonnekes, J., R. Goselink, V. Weerdesteyn and B.R. Bloem, The Retropulsion Test: A Good Evaluation of Postural Instability in Parkinson’s Disease? (1) 43-47
Nunes, R.G., see Reimão, S. (3) 561-567
O’Callaghan, C., see Hall, J.M. (4) 881-891
Odin, P., see Fauser, M. (4) 737-741
Ojeda, N., see Lucas-Jiménez, O. (4) 793-804
Okun, M., see Price, C.C. (4) 893-905
Okun, M.S., see Ellis, C. (2) 403-411
Okun, M.S., see Hassan, A. (2) 313-319
Oliveira-Filho, J., see Almeida, L.R.S. (4) 855-864
Oortwijn, W., see Canoy, M. (3) 575-580
Palladino, R., see Moccia, M. (4) 913-924
Pani, A., see Jiao, Y. (2) 389-401
Panisset, M., see Béland, S.-G. (4) 805-811
Panisset, M., see Daneault, J.-F. (1) 85-93
Parashos, S.A., J. Elm, J.T. Boyd, K.L. Chou, L. Dai, Z. Mari, J.C. Morgan, L. Sudarsky and C.L. Wielinski, Validation of an Ambulatory Capacity Measure in Parkinson Disease: A Construct Derived from the Unified Parkinson’s Disease Rating Scale (1) 67-73
Paul, S.S., see Almeida, L.R.S. (4) 855-864
Pavlovic, D., see Yang, P. (4) 821-836
Pekkonen, E., see Scheperjans, F. (2) 255-262
Peña, J., see Lucas-Jiménez, O. (4) 793-804
Pereira, J.B., see Skogseth, R.E. (4) 783-792
Perju-Dumbrava, L., see Pirker, S. (4) 907-912
Peterson, E.L., see Silbergleit, A.K. (3) 517-524
Phibbs, F.T., see Tramontana, M.G. (1) 151-163
Piazza, S.J., see Sterling, N.W. (1) 141-150
Picillo, M., see Moccia, M. (4) 913-924
Pinto, A., see Domingos, J.M. (3) 453-469
Pirker, S., L. Perju-Dumbrava, G.G. Kovacs, T. Traub-Weidinger and W. Pirker, Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration (4) 907-912
Pirker, W., see Pirker, S. (4) 907-912
Pirogovsky-Turk, E., J.V. Filoteo, I. Litvan and D.L. Harrington, Structural MRI Correlates of Episodic Memory Processes in Parkinson’s Disease Without Mild Cognitive Impairment (4) 971-981
Poewe, W., see Mahlknecht, P. (4) 681-697
Postuma, R.B., see Béland, S.-G. (4) 805-811
Powell, J.J., see Caviness, J.N. (1) 117-124
Preterre, C., A.-G. Corbillé, G. Balloy, F. Letournel, M. Neunlist and P. Derkinderen, Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System (4) 765-772
Price, C.C., S.-A. Levy, J. Tanner, C. Garvan, J. Ward, F. Akbar, D. Bowers, M. Rice and M. Okun, Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson’s Disease: Considerations from a Pilot Study (4) 893-905
Price, C.C., see Cohen, M.L. (4) 961-970
Prodoehl, J., see Lamotte, G. (1) 21-41
Rafferty, M.R., see Lamotte, G. (1) 21-41
Rahimi, J., I. Milenkovic and G.G. Kovacs, Patterns of Tau and α-Synuclein Pathology in the Visual System (2) 333-340
Rau, K., see Brehm, N. (3) 595-604
Ravina, B., see Simon, D.K. (4) 731-736
Reichmann, H., see Klingelhoefer, L. (3) 647-658
Reilly, R.B., see Fearon, C. (4) 925-936
Reimão, S., P.P. Lobo, D. Neutel, L.C. Guedes, M. Coelho, M.M. Rosa, J. Ferreira, D. Abreu, N. Gonçalves, C. Morgado, R.G. Nunes, J. Campos and J.J. Ferreira, Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson’s disease (3) 561-567
Reish, H.E.A. and D.G. Standaert, Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease (1) 1-19
Reizine, N., see Westbay, L.C. (3) 497-504
Reynolds, G.O., see Seichepine, D.R. (1) 75-83
Rice, M., see Price, C.C. (4) 893-905
Richard, I.H., see Dorsey, E.R. (3) 505-515
Rigby, H., see Lin, T.P. (1) 125-130
Riggare, S., see Serrano, J.A. (1) 187-196
Rizzieri, A., see Dorsey, E.R. (3) 505-515
Robledo, I., see Mathur, S. (2) 263-268
Rocker, C., L. Cappelletti, C. Marshall, C.C. Meunier, D.W. Brooks, T. Sherer and S. Chowdhury, Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial Finder (1) 55-66
Rocker, C., see Dorsey, E.R. (3) 505-515
Rodríguez-Violante, M., see Alvarado-Bolaños, A. (3) 541-548
Rolinski, M., see Lawton, M. (2) 269-279
Romero, K., see Stephenson, D. (3) 581-594
Rosa, M.M., see Reimão, S. (3) 561-567
Rose, T.C., see Bettiol, S.S. (3) 425-442
Rosenbek, J.C., see Ellis, C. (2) 403-411
Ross, G.W., see Simon, D.K. (4) 731-736
Rothi, L.J.G., see Ellis, C. (2) 403-411
Rubens, R., see Nausieda, P.A. (4) 837-845
Ruffman, C., see Lawton, M. (2) 269-279
Sabbagh, M.N., see Caviness, J.N. (1) 117-124
Sadikot, A.F., see Daneault, J.-F. (1) 85-93
Saha, R., see Matthews, H. (3) 533-539
Salomon, R.M., see Tramontana, M.G. (1) 151-163
Samuel, M., see Ughratdar, I. (3) 483-496
Santos, A.T., see Ferreira, J.J. (2) 281-290
Sardina, M., see Cattaneo, C. (3) 475-481
Schee, J.P., see Tan, A.H. (4) 865-879
Scheperjans, F., E. Pekkonen, S. Kaakkola and P. Auvinen, Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota? (2) 255-262
Schmidt, P., see Hassan, A. (2) 313-319
Schneider, C.B., see Ma, J.K.-Y. (2) 291-299
Schneider, J., see Bega, D. (4) 773-782
Schrader, C., see Münte, T.F. (3) 613-620
Schwab, N.A., see Cohen, M.L. (4) 961-970
Schwarz, H., see Dorsey, E.R. (3) 505-515
Scullin, M.K., J.A. Fairley, L.M. Trotti, F.C. Goldstein, S.A. Factor and D.L. Bliwise, Sleep Correlates of Trait Executive Function and Memory in Parkinson’s Disease (1) 49-54
Seichepine, D.R., S. Neargarder, S. Davidsdottir, G.O. Reynolds and A. Cronin-Golomb, Side and Type of Initial Motor Symptom Influences Visuospatial Functioning in Parkinson’s Disease (1) 75-83
Semah, F., see Tard, C. (3) 569-574
Seppi, K., see Mahlknecht, P. (4) 681-697
Serrano, J.A., F. Larsen, T. Isaacs, H. Matthews, J. Duffen, S. Riggare, F. Capitanio, J.J. Ferreira, J. Domingos, W. Maetzler, H. Graessner and SENSE-PARK Consortium, Participatory Design in Parkinson’s Research with Focus on the Symptomatic Domains to be Measured (1) 187-196
Serrano, J.A., see Ferreira, J.J. (2) 281-290
Shaham, N., see Sterling, N.W. (1) 141-150
Sharma, S., see Simon, D.K. (4) 731-736
Sherer, T., see Dorsey, E.R. (3) 505-515
Sherer, T., see Rocker, C. (1) 55-66
Sherrington, C., see Almeida, L.R.S. (4) 855-864
Shill, H.A., see Caviness, J.N. (1) 117-124
Shine, J.M., see Hall, J.M. (4) 881-891
Sierra, M., S. Carnicella, A.P. Strafella, A. Bichon, E. Lhommée, A. Castrioto, S. Chabardes, S. Thobois and P. Krack, Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors (3) 625-636
Silbergleit, A.K., P.A. LeWitt, E.L. Peterson and G.M. Gardner, Quantitative Analysis of Voice in Parkinson Disease Compared to Motor Performance: A Pilot Study (3) 517-524
Simon, D.K., T. Simuni, J. Elm, J. Clark-Matott, A.K. Graebner, L. Baker, S.R. Dunlop, M. Emborg, C. Kamp, J.C. Morgan, G.W. Ross, S. Sharma, B. Ravina and On behalf of the NINDS NET-PD Investigators, Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects (4) 731-736
Simon-Tov, S., T. Dinur, N. Giladi, A. Bar-Shira, M. Zelis, A. Zimran and D. Elstein, Color Discrimination in Patients with Gaucher Disease and Parkinson Disease (3) 525-531
Simuni, T., see Bega, D. (4) 773-782
Simuni, T., see Hassan, A. (2) 313-319
Simuni, T., see Lamotte, G. (1) 21-41
Simuni, T., see Simon, D.K. (4) 731-736
Singer, C., see Nausieda, P.A. (4) 837-845
Skogseth, R.E., K. Bronnick, J.B. Pereira, B. Mollenhauer, D. Weintraub, T. Fladby and D. Aarsland, Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s Disease (4) 783-792
Slevin, J.T., H.H. Fernandez, C. Zadikoff, C. Hall, S. Eaton, J. Dubow, K. Chatamra and J. Benesh, Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson’s Disease Patients (1) 165-174
Smeyne, R.J., see Jiao, Y. (2) 389-401
Smith, L.A., see Bettiol, S.S. (3) 425-442
Smith, S.T., see Brodie, M.A.D. (1) 105-116
Sollinger, S., see Ferreira, J.J. (2) 281-290
Song, Y., see Tramontana, M.G. (1) 151-163
Soo, S.K., see Tan, A.H. (4) 865-879
Spiegel, J., see Nausieda, P.A. (4) 837-845
Spiro, A.S., see Abbott, S.K. (1) 175-185
Stamford, J., see Mathur, S. (2) 263-268
Stamford, J., see Matthews, H. (3) 533-539
Standaert, D.G., see Reish, H.E.A. (1) 1-19
Stark, Y., see Stephenson, D. (3) 581-594
Starkstein, S., see Egan, S.J. (3) 443-451
Stephenson, D., M.T. Hu, K. Romero, K. Breen, D. Burn, Y. Ben-Shlomo, A. Bhattaram, M. Isaac, C. Venuto, K. Kubota, M.A. Little, S. Friend, S. Lovestone, H.R. Morris, D. Grosset, M. Sutherland, J. Gallacher, C. Williams-Gray, L.J. Bain, E. Avilés, K. Marek, A.W. Toga, Y. Stark, M.F. Gordon and S. Ford, Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease (3) 581-594
Sterling, N.W., J.P. Cusumano, N. Shaham, S.J. Piazza, G. Liu, L. Kong, G. Du, M.M. Lewis and X. Huang, Dopaminergic Modulation of Arm Swing During Gait Among Parkinson’s Disease Patients (1) 141-150
Storch, A., see Ma, J.K.-Y. (2) 291-299
Strafella, A.P., see Fasano, A. (2) 241-254
Strafella, A.P., see Sierra, M. (3) 625-636
Stroupe, K.T., see Westbay, L.C. (3) 497-504
Sudarsky, L., see Parashos, S.A. (1) 67-73
Sullivan, K.L., J.A. Mortimer, W. Wang, T.A. Zesiewicz, H.J. Brownlee and A.R. Borenstein, Occupational Characteristics and Patterns as Risk Factors for Parkinson’s Disease: A Case Control Study (4) 813-820
Sutherland, M., see Stephenson, D. (3) 581-594
Swallow, D.M.A., see Malek, N. (4) 947-959
Synek, B., see Yang, P. (4) 821-836
Tan, A.H., C.T. Tan, C. Marras, K.W. Loh, N.W.W. Ho, Q.H. Lim, P.W. Tan, C.C. Lim, Y.W. Cheong, S.T. Kong, J.P. Schee, K.H. Tan, S.K. Soo, C. Vanderschaaf, S.L.H. Lew, U.A. Mahamad, K.J. Goh, H.S. Yong and S.-Y. Lim, Knowledge of Parkinson’s Disease in a Multiethnic Urban Asian Setting (4) 865-879
Tan, C.T., see Tan, A.H. (4) 865-879
Tan, K.H., see Tan, A.H. (4) 865-879
Tan, P.W., see Tan, A.H. (4) 865-879
Tanner, J., see Price, C.C. (4) 893-905
Tard, C., A. Delval, A. Duhamel, C. Moreau, D. Devos, L. Defebvre and K. Dujardin, Specific Attentional Disorders and Freezing of Gait in Parkinson’s Disease (2) 379-387
Tard, C., F. Demailly, A. Delval, F. Semah, L. Defebvre, K. Dujardin and C. Moreau, Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson’s Disease (3) 569-574
Taylor, J.-P., see Yarnall, A.J. (4) 743-747
Tessitore, A., see Fasano, A. (2) 241-254
Thobois, S., see Sierra, M. (3) 625-636
Thoms, A., see Ferreira, J.J. (2) 281-290
Thordardottir, B., see Nilsson, M.H. (4) 983-992
Tobin, G., see Mitra, R. (2) 301-311
Toga, A.W., see Stephenson, D. (3) 581-594
Torres, E.R., see Magen, I. (3) 669-680
Tramontana, M.G., A.L. Molinari, P.E. Konrad, T.L. Davis, S.A. Wylie, J.S. Neimat, A.T. May, F.T. Phibbs, P. Hedera, C.E. Gill, R.M. Salomon, L. Wang, Y. Song and D. Charles, Neuropsychological Effects of Deep Brain Stimulation in Subjects with Early Stage Parkinson’s Disease in a Randomized Clinical Trial (1) 151-163
Traub-Weidinger, T., see Pirker, S. (4) 907-912
Trotti, L.M., see Scullin, M.K. (1) 49-54
Turner, C., see Yang, P. (4) 821-836
Ughratdar, I., M. Samuel and K. Ashkan, Technological Advances in Deep Brain Stimulation (3) 483-496
Ullén, S., see Jonasson, S.B. (2) 341-349
Valenca, G.T., see Almeida, L.R.S. (4) 855-864
van de Warrenburg, B.P., see Zach, H. (4) 727-729
van der Eijk, M., B.R. Bloem, F.A.P. Nijhuis, J. Koetsenruijter, H.J.M. Vrijhoef, M. Munneke, M. Wensing and M.J. Faber, Multidisciplinary Collaboration in Professional Networks for PD A Mixed-Method Analysis (4) 937-945
van Vliet, V., see Allen, N.E. (2) 229-239
van Wegen, E.E.H., see Zhao, Y. (2) 369-378
van Wezel, R.J.A., see Zhao, Y. (2) 369-378
Vanderschaaf, C., see Tan, A.H. (4) 865-879
Venuto, C., see Stephenson, D. (3) 581-594
Vrijhoef, H.J.M., see van der Eijk, M. (4) 937-945
Wagner, J.D., see Dorsey, E.R. (3) 505-515
Waldvogel, H., see Yang, P. (4) 821-836
Wallon, D., see Le Goff, F. (1) 95-104
Walton, C.C., see Hall, J.M. (4) 881-891
Wang, L., see Tramontana, M.G. (1) 151-163
Wang, W., see Sullivan, K.L. (4) 813-820
Ward, J., see Price, C.C. (4) 893-905
Weaver, F.M., see Westbay, L.C. (3) 497-504
Weber, P., see Ferreira, J.J. (2) 281-290
Weerdesteyn, V., see Nonnekes, J. (1) 43-47
Weintraub, D., see Skogseth, R.E. (4) 783-792
Wensing, M., see van der Eijk, M. (4) 937-945
Westbay, L.C., L. Cao, I. Burnett-Zeigler, N. Reizine, B. Barton, D. Ippolito, F.M. Weaver and K.T. Stroupe, Mental Health-Related Healthcare Use Following Bilateral Deep Brain Stimulation For Parkinson’s Disease (3) 497-504
Wielinski, C.L., see Parashos, S.A. (1) 67-73
Wilkinson, L., see Williams, I.A. (2) 321-331
Williams, I.A., L. Wilkinson, P. Limousin and M. Jahanshahi, Load-Dependent Interference of Deep Brain Stimulation of the Subthalamic Nucleus with Switching from Automatic to Controlled Processing During Random Number Generation in Parkinson’s Disease (2) 321-331
Williams, N.M., see Malek, N. (4) 947-959
Williams-Gray, C., see Stephenson, D. (3) 581-594
Winder, M., see Mitra, R. (2) 301-311
Wolfson, C., see Béland, S.-G. (4) 805-811
Wood, N., see Malek, N. (4) 947-959
Wu, S.S., see Hassan, A. (2) 313-319
Wylie, S.A., see Tramontana, M.G. (1) 151-163
Yang, K.M., see Kelm-Nelson, C.A. (4) 749-763
Yang, P., D. Pavlovic, H. Waldvogel, M. Dragunow, B. Synek, C. Turner, R. Faull and J. Guan, String Vessel Formation is Increased in the Brain of Parkinson Disease (4) 821-836
Yarnall, A.J., R.A. Lawson, G.W. Duncan, D.P. Breen, T.K. Khoo, D. Brooks, R.A. Barker, J.-P. Taylor and D.J. Burn, Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson’s Disease? (4) 743-747
Yong, H.S., see Tan, A.H. (4) 865-879
Zach, H., M. Dirkx, B.R. Bloem and R.C. Helmich, The Clinical Evaluation of Parkinson’s Tremor (3) 471-474
Zach, H., W.L.J. Gerrits, B.P. van de Warrenburg and B.R. Bloem, A Positive ‘Pointing Test’ in a Parkinson’s Disease Patient (4) 727-729
Zadikoff, C., see Slevin, J.T. (1) 165-174
Zelis, M., see Simon-Tov, S. (3) 525-531
Zesiewicz, T.A., see Sullivan, K.L. (4) 813-820
Zhang, Y., see Bega, D. (4) 773-782
Zhao, Y., T. Heida, E.E.H. van Wegen, B.R. Bloem and R.J.A. van Wezel, E-health Support in People with Parkinson’s Disease with Smart Glasses: A Survey of User Requirements and Expectations in the Netherlands (2) 369-378
Zijlmans, J.C., see Haaxma, C.A. (4) 847-853
Zimran, A., see Simon-Tov, S. (3) 525-531
Zuñiga-Ramírez, C., see Alvarado-Bolaños, A. (3) 541-548
